Tanezumab Dances Through Back Pain Studies With “Acceptable” Safety Answers

Tango
Data from the tanezumab's latest TANGO study was statistically significant in its highest dosage • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D